Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Strides Pharma Science LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:532531NSE Symbol: STARP/E(TTM):112.16
ISIN Demat:INE939A01011Div & Yield %:0.43EPS(TTM):8.3
Book Value(Rs):344.5797109Market Cap ( Cr.):8580.36Face Value(Rs):10
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 2139.421866.121854.501979.001857.571691.93
Excise Duty0.000.000.000.000.000.00
Net Sales2139.421866.121854.501979.001857.571691.93
Other Income 2873.24127.5484.07123.49117.0993.07
Stock Adjustments 27.20-14.87-21.04-114.26117.532.88
Total Income5039.861978.791917.531988.232092.191787.88
EXPENDITURE :      
Raw Materials 1110.74954.291044.57987.261106.41894.84
Power & Fuel Cost36.0047.9045.5443.7645.8244.53
Employee Cost 377.59348.92267.01272.09272.72230.23
Other Manufacturing Expenses 132.85143.04130.03151.87134.86117.43
Selling and Administration Expenses 246.18192.14182.64260.83171.51117.95
Miscellaneous Expenses 0.8519.8380.1972.3184.5685.37
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure1904.211706.111749.981788.121815.871490.35
Operating Profit3135.66272.68167.54200.11276.32297.53
Interest 145.91139.38138.6874.2465.3466.84
Gross Profit2989.75133.3028.86125.87210.98230.69
Depreciation84.6187.4193.62104.3799.3494.24
Profit Before Tax2905.1445.89-64.7621.50111.64136.45
Tax-1.46-0.12-49.84-169.6633.6518.76
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax20.391.46-19.6010.98-0.26-2.59
Reported Net Profit2886.2144.554.68180.1978.24120.28
Extraordinary Items -0.12-5.53-16.324.233.263.41
Adjusted Net Profit2886.3350.0821.00175.9674.98116.87
Adjst. below Net Profit -2827.06-57.190.000.000.00-57.25
P & L Balance brought forward719.38745.57740.89583.13522.80616.08
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 22.9913.550.0022.4317.91156.30
P & L Balance carried down755.55719.38745.57740.89583.13522.80
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %40.0025.0015.000.0025.00140.00
Earnings Per Share-Unit Curr313.164.850.5220.078.7213.43
Earnings Per Share(Adj)-Unit Curr313.162.130.238.793.825.88
Book Value-Unit Curr346.42383.84380.71379.36362.18352.68